North America Pharmaceutical Contract Packaging Market Report by Industry (Small Molecule, Biopharmaceutical, Vaccine), Type (Sterile, Non-Sterile), Packaging (Plastic Bottles, Caps and Closures, Blister Packs, Prefilled Syringes, Parenteral Vials and Amp

North America Pharmaceutical Contract Packaging Market Report by Industry (Small Molecule, Biopharmaceutical, Vaccine), Type (Sterile, Non-Sterile), Packaging (Plastic Bottles, Caps and Closures, Blister Packs, Prefilled Syringes, Parenteral Vials and Ampoules, and Others), and Country 2024-2032

The North America pharmaceutical contract packaging market size reached US$ 8.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.9 Billion by 2032, exhibiting a growth rate (CAGR) of 7.2% during 2024-2032.

Pharmaceutical contract packaging refers to third-party packaging services, facilities and equipment offered for pharmaceutical products. There are different forms of packaging that are available in the market, which include bottles, pouches, packets, sachets, folding cartons, stick packs, jars, blister and clamshell packages. Pharmaceutical contract packaging offers several benefits in warehousing, supply chain management, barcoding, regulated production, fabrication, designing, and prototyping of pharmaceutical products. Thus, the versatile nature of contract packaging, coupled with various technological advancements has positively influenced its demand across the globe.

The North America pharmaceutical contract packaging market is currently being driven by several factors. The escalating adoption of innovative packaging methods to satisfy rapidly changing consumer preferences and rising environmental concerns have stimulated the demand for contract packaging in the pharmaceutical industry. In addition to this, rising penetration of automation in pharmaceutical contract packaging has minimized risks of human handling errors, thereby catalyzing market growth in the region. Apart from this, high disposable incomes, coupled with rising consumer health awareness, are propelling the demand for pharmaceutical contract packaging in the region.

IMARC Group’s latest report provides a deep insight into the North America pharmaceutical contract packaging market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the North America pharmaceutical contract packaging market in any manner.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the North America pharmaceutical contract packaging market report, along with forecasts at the regional and country levels from 2024-2032. Our report has categorized the market based on industry, type and packaging.

Key Regions Analysed
United States
Canada

Analysis for Each Country

Market by Industry
Small Molecule
Biopharmaceutical
Vaccine

Market by Type
Sterile
Non-Sterile

Market by Packaging
Plastic Bottles
Caps and Closures
Blister Packs
Prefilled Syringes
Parenteral Vials and Ampoules
Others

Value Chain Analysis
Key Drivers and Challenges
Porters Five Forces Analysis
Competitive Landscape
Competitive Structure
Key Player Profiles

Key Questions Answered in This Report:
How has the North America pharmaceutical contract packaging market performed so far and how will it perform in the coming years?
What are the key regions in the North America pharmaceutical contract packaging market?
What has been the impact of COVID-19 on the North America pharmaceutical contract packaging market?
What is the breakup of the North America pharmaceutical contract packaging market on the basis of industry?
What is the breakup of the North America pharmaceutical contract packaging market on the basis of type?
What is the breakup of the North America pharmaceutical contract packaging market on the basis of packaging?
What are the various stages in the value chain of the North America pharmaceutical contract packaging industry?
What are the key driving factors and challenges in the North America pharmaceutical contract packaging industry?
What is the structure of the North America pharmaceutical contract packaging industry and who are the key players?
What is the degree of competition in the North America pharmaceutical contract packaging industry?